Sarepta Therapeutics, Inc. SRPT Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s software and technology licenses, net?
- Sarepta Therapeutics, Inc. (SRPT) reported software and technology licenses, net of $151.96M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Sarepta Therapeutics, Inc.'s software and technology licenses, net increased by 88.6% year-over-year, from $80.55M to $151.96M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s software and technology licenses, net has grown at a -5.3% compound annual growth rate (CAGR), from $203.7M to $155.55M.